Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Mol Pharm. 2010 Aug 2;7(4):1209–1222. doi: 10.1021/mp100043h

Figure 5.

Figure 5

Cell viability of MCF 7 cells treated with Cyt C encapsulating HBPH nanoparticles (Cyt C-HBPH NPs) compared to that of cells treated with the non-encapsulated nanoparticle (HBPH NPs) and non-treated cells (control). The protein encapsulating HBPH nanoparticles induced a significant reduction in the cell (MCF 7) viability after 6 h of incubation, where the non-encapsulated nanoparticle (HBPH NPs) showed no significant cytotoxicity. Control cells (MCF 7) were treated with 1× PBS. Average values of four measurements were depicted ± standard error.